Use of the neo-adjuvant exemestane in post-menopausal estrogen receptor-positive breast cancer: A randomized phase II trial (PTEX46) to investigate the optimal duration of preoperative endocrine therapy

Authors:

Abstract
No abstract available

This publication has 13 references indexed in Scilit: